0.63
3.02%
-0.0196
VBI Vaccines Inc. Aktie (VBIV) Neueste Nachrichten
Has VBI Vaccines (VBIV) Outpaced Other Medical Stocks This Year? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
3-Antigen Hepatitis B Vaccine Successfully Scales — Precision Vaccinations News - Precision Vaccinations
Precision Vaccinations
VBI Vaccines' Revenue Soars, Promising Vaccine Trials - TipRanks.com - TipRanks
TipRanks
VBI Vaccines Updates Share Sale Agreements and Partnerships - TipRanks.com - TipRanks
TipRanks
VBI Vaccines Reports First Quarter 2024 Financial Results - Business Wire
Business Wire
VBI Vaccines, Inc. (VBIV) Upgraded to Strong Buy: Here's Why - Yahoo Movies UK
Yahoo Movies UK
StockNews.com Initiates Coverage on VBI Vaccines (NASDAQ:VBIV) - Defense World
Defense World
VBI Vaccines (NASDAQ:VBIV) Research Coverage Started at StockNews.com - Defense World
Defense World
VBI Vaccines (NASDAQ:VBIV) Receives New Coverage from Analysts at StockNews.com - Defense World
Defense World
VBI Vaccines Soars with Hepatitis B Vaccine Success - TipRanks.com - TipRanks
TipRanks
VBI Vaccines Reports Full Year 2023 Financial Results - Business Wire
Business Wire
3-antigen Hepatitis B Vaccine Reports Positive Early 2024 Results - Precision Vaccinations
Precision Vaccinations
It would be worthwhile to take a closer look at VBI Vaccines Inc. (VBIV) – US Post News - US Post News
US Post News
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Markets Insider
Markets Insider
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket - Markets Insider
Markets Insider
VBI Vaccines to Present Early Phase 2b Cancer Vaccine Results - TipRanks.com - TipRanks
TipRanks
VBI Vaccines to Present Early Phase 2b Cancer Vaccine Results - TipRanks.com - TipRanks
TipRanks
VBI Vaccines Boosts Canadian Govt Partnership - TipRanks.com - TipRanks
TipRanks
VBI Vaccines Bolsters Collaboration with Canadian Government - TipRanks.com - TipRanks
TipRanks
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched ... - Business Wire
Business Wire
VBI Vaccines signs agreement with Canada to develop COVID-19 vaccine by 2022 - Yahoo News Australia
Yahoo News Australia
Scientists search for a universal coronavirus vaccine - upworthyscience.com
upworthyscience.com
Vaccine News — Precision Vaccinations News - Precision Vaccinations
Precision Vaccinations
Thinking about buying stock in Arena Group, Dunxin Financial Holdings, Nano-X Imaging, VBI Vaccines, or SuRo ... - Marketscreener.com
Marketscreener.com
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
VBI Vaccines Advances Strategy with Key Financial Moves - TipRanks.com - TipRanks
TipRanks
Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Benzinga
Late-stage Hepatitis B Virus Development Programs Enter New Agreements - Precision Vaccinations
Precision Vaccinations
Brii Biosciences Announces Agreement to Acquire VBI's IP Rights in BRII-179 (VBI-2601) and Plans to Initiate ... - PR Newswire
PR Newswire
Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Benzinga
VBI-1901 Demonstrates Encouraging Clinical Activity in Recurrent GBM - Targeted Oncology
Targeted Oncology
VBI Vaccines Reports Third Quarter 2023 Financial Results - VBI Vaccines
VBI Vaccines
VBI Vaccines announces mRNA-launched eVLP technology - BioWorld Online
BioWorld Online
VBI Vaccines' pan-coronavirus vaccine candidate produced broad protection against COVID variants of concern - MarketWatch
MarketWatch
VBI Vaccines Reports Second Quarter 2023 Financial Results - VBI Vaccines
VBI Vaccines
Brii expands hepatitis B partnership with VBI in deal worth $437M - BioWorld Online
BioWorld Online
Why Is VBI Vaccines (VBIV) Stock Down 40% Today? - InvestorPlace
InvestorPlace
VBI Vaccines and Brii Biosciences Expand Hepatitis B Partnership To Address Both Prevention and Treatment in ... - Business Wire
Business Wire
VBI Vaccines Reports First Quarter 2023 Financial Results - VBI Vaccines
VBI Vaccines
VBI Vaccines stock falls on portfolio overhaul, reverse stock split - Seeking Alpha
Seeking Alpha
VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Misses Revenue Estimates - Yahoo News UK
Yahoo News UK
VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in ... - Business Wire
Business Wire
Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri® - Valneva
Valneva
VBI Vaccines Reports Second Quarter 2022 Financial Results and Provides Corporate Update - VBI Vaccines
VBI Vaccines
VBI Vaccines Inc (NASDAQ: VBIV) Receives Orphan Drug Designation For VBI-1901 for Glioblastoma Treatment - BP Journal
BP Journal
VBI Vaccines Announces New Data and Progress of VBI-2900, VBI's eVLP Coronavirus Program - Business Wire
Business Wire
VBI Vaccines Announces FDA Approval of PreHevbrio™ for the Prevention of Hepatitis B in Adults - Business Wire
Business Wire
VBIV Stock: Hepatitis Vaccine Approval Can Be Valuation Catalyst - Seeking Alpha
Seeking Alpha
Kapitalisierung:
|
Volumen (24h):